Cargando…
CDX2 hox gene product in a rat model of esophageal cancer
BACKGROUND: Barrett's mucosa is the precursor of esophageal adenocarcinoma. The molecular mechanisms behind Barrett's carcinogenesis are largely unknown. Experimental models of longstanding esophageal reflux of duodenal-gastric contents may provide important information on the biological s...
Autores principales: | Ingravallo, Giuseppe, Dall'Olmo, Luigi, Segat, Daniela, Fassan, Matteo, Mescoli, Claudia, Dazzo, Emanuela, Castoro, Carlo, Polimeno, Lorenzo, Rizzetto, Christian, Baroni, Maurizio David, Zaninotto, Giovanni, Ancona, Ermanno, Rugge, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225830/ https://www.ncbi.nlm.nih.gov/pubmed/19664209 http://dx.doi.org/10.1186/1756-9966-28-108 |
Ejemplares similares
-
Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study
por: Dall’Olmo, Luigi, et al.
Publicado: (2014) -
Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
por: Cavallin, Francesco, et al.
Publicado: (2017) -
Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
por: Carraro, Amedeo, et al.
Publicado: (2017) -
CD80 expression promotes immune surveillance in Barrett’s metaplasia
por: Scarpa, Melania, et al.
Publicado: (2019) -
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
por: Fassan, Matteo, et al.
Publicado: (2016)